Variant report
Variant | esv3336599 |
---|---|
Chromosome Location | chr12:42255175-42255641 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145221701 | chr12:42255189-42255190 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73274236 | chr12:42255208-42255209 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs117777326 | chr12:42255218-42255219 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs11181200 | chr12:42255234-42255235 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs10880175 | chr12:42255244-42255245 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs538210874 | chr12:42255260-42255261 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371642731 | chr12:42255264-42255265 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556262534 | chr12:42255265-42255266 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs574811640 | chr12:42255293-42255294 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536149112 | chr12:42255308-42255309 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73128159 | chr12:42255359-42255360 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11181201 | chr12:42255366-42255367 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs143784726 | chr12:42255375-42255376 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs11181202 | chr12:42255396-42255397 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs376673564 | chr12:42255412-42255413 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs565304415 | chr12:42255433-42255434 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11181203 | chr12:42255435-42255436 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs113835326 | chr12:42255440-42255441 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562328227 | chr12:42255573-42255574 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529734203 | chr12:42255601-42255602 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548597723 | chr12:42255607-42255608 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs146857189 | chr12:42255613-42255614 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs527852928 | chr12:42255621-42255622 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs71453322 | chr12:42255623-42255624 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Autism | 20858243 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:42218600-42257000 | Weak transcription | Aorta | Aorta |
2 | chr12:42250600-42257400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr12:42250800-42255400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr12:42254800-42255400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
5 | chr12:42254800-42255600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr12:42255400-42256000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |